BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34528404)

  • 1. Elevated emotion reactivity and emotion regulation in individuals at clinical high risk for developing psychosis and those diagnosed with a psychotic disorder.
    Vines L; Bridgwater M; Bachman P; Hayes R; Catalano S; Jalbrzikowski M
    Early Interv Psychiatry; 2022 Jul; 16(7):724-735. PubMed ID: 34528404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emotion regulation and social knowledge in youth at clinical high-risk for psychosis and outpatients with chronic schizophrenia: Associations with functional outcome and negative symptoms.
    Macfie WG; Spilka MJ; Bartolomeo LA; Gonzalez CM; Strauss GP
    Early Interv Psychiatry; 2023 Jan; 17(1):21-28. PubMed ID: 35362242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium.
    Alderman T; Addington J; Bearden C; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
    Early Interv Psychiatry; 2015 Dec; 9(6):467-75. PubMed ID: 24576057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurophysiological Correlate of Emotion Regulation by Cognitive Reappraisal and Its Association With Psychotic Symptoms in Early Psychosis.
    Kim M; Hwang WJ; Park J; Kim T; Oh S; Kwon JS
    Schizophr Bull; 2021 Jan; 47(1):87-96. PubMed ID: 32609340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor Analysis of Negative Symptom Items in the Structured Interview for Prodromal Syndromes.
    Azis M; Strauss GP; Walker E; Revelle W; Zinbarg R; Mittal V
    Schizophr Bull; 2019 Sep; 45(5):1042-1050. PubMed ID: 30535399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of emotion awareness and regulation on social functioning in individuals at clinical high risk for psychosis.
    Kimhy D; Gill KE; Brucato G; Vakhrusheva J; Arndt L; Gross JJ; Girgis RR
    Psychol Med; 2016 Oct; 46(14):2907-2918. PubMed ID: 27050714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis.
    Modinos G; Kempton MJ; Tognin S; Calem M; Porffy L; Antoniades M; Mason A; Azis M; Allen P; Nelson B; McGorry P; Pantelis C; Riecher-Rössler A; Borgwardt S; Bressan R; Barrantes-Vidal N; Krebs MO; Nordentoft M; Glenthøj B; Ruhrmann S; Sachs G; Rutten B; van Os J; de Haan L; Velthorst E; van der Gaag M; Valmaggia LR; McGuire P;
    JAMA Psychiatry; 2020 Feb; 77(2):190-200. PubMed ID: 31722018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.
    Carrión RE; Auther AM; McLaughlin D; Olsen R; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cornblatt BA
    Schizophr Bull; 2019 Jun; 45(4):763-772. PubMed ID: 30351423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological, social and role functioning as predictors of psychosis in an adolescent psychiatric sample.
    Ärmänen A; Lahti M; Therman S; Suvisaari J; Lindgren M
    Early Interv Psychiatry; 2018 Dec; 12(6):1064-1071. PubMed ID: 28124493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal social behavior in youths with psychotic illness and those at clinical high risk.
    Jalbrzikowski M; Krasileva KE; Marvin S; Zinberg J; Andaya A; Bachman P; Cannon TD; Bearden CE
    Dev Psychopathol; 2013 Nov; 25(4 Pt 1):1187-97. PubMed ID: 24229557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affective dysfunctions in adolescents at risk for psychosis: emotion awareness and social functioning.
    van Rijn S; Schothorst P; Wout Mv; Sprong M; Ziermans T; van Engeland H; Aleman A; Swaab H
    Psychiatry Res; 2011 May; 187(1-2):100-5. PubMed ID: 21094533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emotional and behavioral symptomatology reported by help-seeking youth at clinical high-risk for psychosis.
    Thompson E; Kline E; Ellman LM; Mittal V; Reeves GM; Schiffman J
    Schizophr Res; 2015 Mar; 162(1-3):79-85. PubMed ID: 25638728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coping styles of individuals at clinical high risk for developing psychosis.
    Jalbrzikowski M; Sugar CA; Zinberg J; Bachman P; Cannon TD; Bearden CE
    Early Interv Psychiatry; 2014 Feb; 8(1):68-76. PubMed ID: 23164368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emotion regulation across the psychosis continuum.
    Chapman HC; Visser KF; Mittal VA; Gibb BE; Coles ME; Strauss GP
    Dev Psychopathol; 2020 Feb; 32(1):219-227. PubMed ID: 30739633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in facial expressivity in youth at clinical high-risk for psychosis.
    Gupta T; Haase CM; Strauss GP; Cohen AS; Mittal VA
    J Abnorm Psychol; 2019 May; 128(4):341-351. PubMed ID: 30869926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis.
    ; Jalbrzikowski M; Hayes RA; Wood SJ; Nordholm D; Zhou JH; Fusar-Poli P; Uhlhaas PJ; Takahashi T; Sugranyes G; Kwak YB; Mathalon DH; Katagiri N; Hooker CI; Smigielski L; Colibazzi T; Via E; Tang J; Koike S; Rasser PE; Michel C; Lebedeva I; Hegelstad WTV; de la Fuente-Sandoval C; Waltz JA; Mizrahi R; Corcoran CM; Resch F; Tamnes CK; Haas SS; Lemmers-Jansen ILJ; Agartz I; Allen P; Amminger GP; Andreassen OA; Atkinson K; Bachman P; Baeza I; Baldwin H; Bartholomeusz CF; Borgwardt S; Catalano S; Chee MWL; Chen X; Cho KIK; Cooper RE; Cropley VL; Dolz M; Ebdrup BH; Fortea A; Glenthøj LB; Glenthøj BY; de Haan L; Hamilton HK; Harris MA; Haut KM; He Y; Heekeren K; Heinz A; Hubl D; Hwang WJ; Kaess M; Kasai K; Kim M; Kindler J; Klaunig MJ; Koppel A; Kristensen TD; Kwon JS; Lawrie SM; Lee J; León-Ortiz P; Lin A; Loewy RL; Ma X; McGorry P; McGuire P; Mizuno M; Møller P; Moncada-Habib T; Muñoz-Samons D; Nelson B; Nemoto T; Nordentoft M; Omelchenko MA; Oppedal K; Ouyang L; Pantelis C; Pariente JC; Raghava JM; Reyes-Madrigal F; Roach BJ; Røssberg JI; Rössler W; Salisbury DF; Sasabayashi D; Schall U; Schiffman J; Schlagenhauf F; Schmidt A; Sørensen ME; Suzuki M; Theodoridou A; Tomyshev AS; Tor J; Værnes TG; Velakoulis D; Venegoni GD; Vinogradov S; Wenneberg C; Westlye LT; Yamasue H; Yuan L; Yung AR; van Amelsvoort TAMJ; Turner JA; van Erp TGM; Thompson PM; Hernaus D
    JAMA Psychiatry; 2021 Jul; 78(7):753-766. PubMed ID: 33950164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the role of negative symptoms in determining social functioning in individuals at clinical high risk of psychosis.
    Schlosser DA; Campellone TR; Biagianti B; Delucchi KL; Gard DE; Fulford D; Stuart BK; Fisher M; Loewy RL; Vinogradov S
    Schizophr Res; 2015 Dec; 169(1-3):204-208. PubMed ID: 26530628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social cognition over time in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort.
    Piskulic D; Liu L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
    Schizophr Res; 2016 Mar; 171(1-3):176-81. PubMed ID: 26785807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Schizophr Res; 2017 Nov; 189():19-26. PubMed ID: 28139360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anomalous self-experiences are strongly associated with negative symptoms in a clinical high-risk for psychosis sample.
    Værnes TG; Røssberg JI; Møller P
    Compr Psychiatry; 2019 Aug; 93():65-72. PubMed ID: 31351243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.